JP2024518710A5 - - Google Patents

Info

Publication number
JP2024518710A5
JP2024518710A5 JP2023562483A JP2023562483A JP2024518710A5 JP 2024518710 A5 JP2024518710 A5 JP 2024518710A5 JP 2023562483 A JP2023562483 A JP 2023562483A JP 2023562483 A JP2023562483 A JP 2023562483A JP 2024518710 A5 JP2024518710 A5 JP 2024518710A5
Authority
JP
Japan
Prior art keywords
formula
ionizable lipid
polymerosome
ionizable
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023562483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518710A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/059701 external-priority patent/WO2022218957A1/en
Publication of JP2024518710A publication Critical patent/JP2024518710A/ja
Publication of JP2024518710A5 publication Critical patent/JP2024518710A5/ja
Pending legal-status Critical Current

Links

JP2023562483A 2021-04-12 2022-04-12 可溶性封入ポリヌクレオチドとイオン化可能脂質とを含むポリマーソームならびにその作製および使用方法 Pending JP2024518710A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21167911 2021-04-12
EP21167911.3 2021-04-12
PCT/EP2022/059701 WO2022218957A1 (en) 2021-04-12 2022-04-12 Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof

Publications (2)

Publication Number Publication Date
JP2024518710A JP2024518710A (ja) 2024-05-02
JP2024518710A5 true JP2024518710A5 (cg-RX-API-DMAC10.html) 2025-04-21

Family

ID=75786882

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023562483A Pending JP2024518710A (ja) 2021-04-12 2022-04-12 可溶性封入ポリヌクレオチドとイオン化可能脂質とを含むポリマーソームならびにその作製および使用方法

Country Status (8)

Country Link
US (1) US20250281405A1 (cg-RX-API-DMAC10.html)
EP (1) EP4322922A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024518710A (cg-RX-API-DMAC10.html)
CN (1) CN117440798A (cg-RX-API-DMAC10.html)
AU (1) AU2022258552A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023021224A2 (cg-RX-API-DMAC10.html)
CA (1) CA3214934A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022218957A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250381150A1 (en) 2024-03-08 2025-12-18 Genzyme Corporation Lipid nanoparticles
WO2026030375A2 (en) 2024-07-30 2026-02-05 Genzyme Corporation Lipid nanoparticles and methods of manufacture and use thereof
WO2026142951A1 (en) 2024-12-23 2026-07-02 Genzyme Corporation Pharmaceutical system

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5625A (en) 1848-06-13 Machinery for cutting and punching copper sheathing
US569825A (en) 1896-10-20 John h
US70185A (en) 1867-10-29 fan oh be
US5545A (en) 1848-05-02 Improvement in machinery for separating gold
US807A (en) 1838-06-27 Samuel gilson
US567A (en) 1838-01-09 Machine for r-uibbii
US980A (en) 1838-10-13 Improvement in the mode of hardening or chilling the hubs of car and other wheels
US4816A (en) 1846-10-17 Bell machinery for hotels
US669A (en) 1838-04-02 In the manufacture of gunpowder
US2003A (en) 1841-03-12 Improvement in horizontal windivhlls
US16A (en) 1836-08-31 Edwin m
US4676A (en) 1846-07-31 roller
US5591A (en) 1848-05-23 Pump fob
US5661A (en) 1848-07-11 Boring and mortising machine
US633425A (en) 1899-01-26 1899-09-19 Louis Henry Clyborne Wire-tightener.
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
JP3101690B2 (ja) 1987-03-18 2000-10-23 エス・ビィ・2・インコーポレイテッド 変性抗体の、または変性抗体に関する改良
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
IE922437A1 (en) 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
DE69308573T2 (de) 1992-08-17 1997-08-07 Genentech Inc Bispezifische immunoadhesine
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
DE19544393A1 (de) 1995-11-15 1997-05-22 Hoechst Schering Agrevo Gmbh Synergistische herbizide Mischungen
EP0983303B1 (en) 1997-05-21 2006-03-08 Biovation Limited Method for the production of non-immunogenic proteins
AU776910B2 (en) 1998-12-08 2004-09-23 Merck Patent Gesellschaft Mit Beschrankter Haftung Modifying protein immunogenicity
US8323696B2 (en) 2008-08-29 2012-12-04 Ecole Polytechnique Federale De Lausanne Nanoparticles for immunotherapy
US10364350B2 (en) 2009-04-20 2019-07-30 Agency For Science, Technology And Research Vesicular system and uses thereof
WO2012018306A1 (en) 2010-08-05 2012-02-09 Agency For Science, Technology And Research A multicompartmentalized vesicular structure and a method for forming the same
CA3170184A1 (en) 2012-03-12 2013-09-19 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
CN111450060A (zh) 2012-11-19 2020-07-28 新加坡科技研究局 用于引发对免疫原的免疫响应的方法
EP2898894A1 (en) 2014-01-27 2015-07-29 LTS LOHMANN Therapie-Systeme AG Nano-in-micro particles for intradermal delivery
WO2016154432A1 (en) 2015-03-24 2016-09-29 VaxLiant, LLC Adjuvant compositions and related methods
EP3162361A1 (en) * 2015-11-02 2017-05-03 Universität für Bodenkultur Wien Improved magnetically reactive vesicular bodies
JP7542257B2 (ja) * 2018-01-25 2024-08-30 エイシーエム バイオラブズ プライベート リミテッド 可溶化された封入抗原を含むポリマーソーム、ならびにその作製および使用方法
WO2020058239A1 (en) * 2018-09-18 2020-03-26 Universiteit Gent Therapeutic nanoparticles and methods of use thereof

Similar Documents

Publication Publication Date Title
JP7418419B2 (ja) 核酸送達のための第三級アミノ脂質化カチオン性ペプチド
JP2021512142A5 (cg-RX-API-DMAC10.html)
AU2014310934B2 (en) Respiratory syncytial virus (RSV) vaccine
CN115867654A (zh) Rna构建体及其用途
WO2013113736A1 (en) Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen
KR20100016280A (ko) 양이온성 기 및 소수성 기로 작용기화된 폴리글루탐산 및 이의 용도, 특히 이의 치료적 용도
CN115944722B (zh) 一种抗肿瘤mRNA疫苗及其制备方法和应用
EP4132586A1 (en) Carriers for efficient nucleic acid delivery
JP7657773B2 (ja) 核酸送達のための脂質化カチオン性ペプチド-peg組成物
AU2003228229B2 (en) DNA vaccine against proliferating endothelial cells and methods of use thereof
CA2730686A1 (en) Anti-amyloid immunogenic compositions, methods and uses
Du et al. Protein corona-driven nanovaccines improve antigen intracellular release and immunotherapy efficacy
CN102834435B (zh) 支化的紧凑型聚乙二醇衍生物
HU230122B1 (hu) Rekombináns vakcina West Nile vírus ellen
KR100568013B1 (ko) 인플루엔자 바이러스에 대한 백신 및 그 제조방법
WO2001081371A1 (en) Gd3-mimetic peptides
KR102836820B1 (ko) 히알루론산-지질 유도체, 이를 포함하는 지질나노입자 및 그 용도
JPH0454131A (ja) 細胞毒性tリンパ球の特異的誘導用合成ワクチン
JP2025508798A5 (cg-RX-API-DMAC10.html)
JP2024500360A5 (cg-RX-API-DMAC10.html)
AU2020234026A1 (en) mRNA vaccine
WO2024131717A1 (zh) 一种阳离子脂质材料的制备及应用
WO2001083698A2 (en) Compositions and methods for inducing activation of dendritic cells
JP4223813B2 (ja) 免疫増強特性を有するムチンペプチド
HK40099133A (zh) Rna构建体及其用途